Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 127-133

  Iwata, Arifumi ^a   Watanabe, Norihiko ^a   Oya, Yoshihiro ^a   Owada, Takayoshi ^a   Ikeda, Kei ^a   Suto, Akira ^a   Kagami, Shin Ichiro ^a   Hirose, Koichi ^a   Kanari, Hiroko ^a   Kawashima, Saki ^a   Nakayama, Toshinori ^a   Taniguchi, Masaru ^b   Iwamoto, Itsuo ^c   Nakajima, Hiroshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; BTLA PROTEIN, MOUSE; CONCANAVALIN A; IMMUNOGLOBULIN RECEPTOR; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; HEPATITIS; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; WILD TYPE; ADOPTIVE TRANSFER; ANIMAL; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ADOPTIVE TRANSFER; ANIMALS; CONCANAVALIN A; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPATITIS; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MITOGENS; NATURAL KILLER T-CELLS; RECEPTORS, IMMUNOLOGIC;

EID: 73949106316     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900389     Document Type: Article

References (35)

1. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
2. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
3. Watanabe, N., M. Gavrieli, J. R. Sedy, J. Yang, F. Fallarino, S. K. Loftin, M. A. Hurchla, N. Zimmerman, J. Sim, X. Zang, et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4: 670-679.
4. Han, P., O. D. Goularte, K. Rufner, B. Wilkinson, and J. Kaye. 2004. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172: 5931-5939. (Pubitemid 38621192)
5. Murphy, K. M., C. A. Nelson, and J. R. Sedý. 2006. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat. Rev. Immunol. 6: 671-681.
6. + T cells. J. Immunol. 174: 3377-3385.
7. Gonzalez, L. C., K. M. Loyet, J. Calemine-Fenaux, V. Chauhan, B. Wranik, W. Ouyang, and D. L. Eaton. 2005. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. USA 102: 1116-1121.
8. Sedy, J. R., M. Gavrieli, K. G. Potter, M. A. Hurchla, R. C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C. F. Ware, T. L. Murphy, et al. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6: 90-98.
9. Tao, R., L. Wang, R. Han, T. Wang, Q. Ye, T. Honjo, T. L. Murphy, K. M. Murphy, and W. W. Hancock. 2005. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J. Immunol. 175: 5774-5782.
10. Deppong, C., T. I. Juehne, M. Hurchla, L. D. Friend, D. D. Shah, C. M. Rose, T. L. Bricker, L. P. Shornick, E. C. Crouch, T. L. Murphy, et al. 2006. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J. Immunol. 176: 3909-3913.
11. Tamachi, T., N. Watanabe, Y. Oya, S. Kagami, K. Hirose, Y. Saito, I. Iwamoto, and H. Nakajima. 2007. B and T lymphocyte attenuator inhibits antigen-induced eosinophil recruitment into the airways. Int. Arch. Allergy Immunol. 143(Suppl 1): 50-55.
12. Steinberg, M. W., O. Turovskaya, R. B. Shaikh, G. Kim, D. F. McCole, K. Pfeffer, K. M. Murphy, C. F. Ware, and M. Kronenberg. 2008. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J. Exp. Med. 205: 1463-1476.
13. Oya, Y., N. Watanabe, T. Owada, M. Oki, K. Hirose, A. Suto, S. Kagami, H. Nakajima, T. Kishimoto, I. Iwamoto, et al. 2008. Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator. Arthritis Rheum. 58: 2498-2510.
14. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21: 483-513.
15. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
16. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159: 2240-2249.
17. Ikarashi, Y., R. Mikami, A. Bendelac, M. Terme, N. Chaput, M. Terada, T. Tursz, E. Angevin, F. A. Lemonnier, H.Wakasugi, et al. 2001. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon γ production. J. Exp. Med. 194: 1179-1186.
18. Kaneda, H., K. Takeda, T. Ota, Y. Kaduka, H. Akiba, Y. Ikarashi, H. Wakasugi, M. Kronenberg, K. Kinoshita, H. Yagita, et al. 2005. ICOS costimulates invariant NKT cell activation. Biochem. Biophys. Res. Commun. 327: 201-207.
19. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi. 2000. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105-114.
20. Takeda, K., Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. U.S.A. 97: 5498-5503.
21. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL- 12-mediated rejection of tumors. Science 278: 1623-1626.
22. Watarai, H., R. Nakagawa, M. Omori-Miyake, N. Dashtsoodol, and M. Taniguchi. 2008. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat. Protoc. 3: 70-78.
23. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203.
24. Mizuhara, H., E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179: 1529-1537.
25. Mizuhara, H., M. Uno, N. Seki, M. Yamashita, M. Yamaoka, T. Ogawa, K. Kaneda, T. Fujii, H. Senoh, and H. Fujiwara. 1996. Critical involvement of interferon g in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23: 1608-1615.
26. Louis, H., O. Le Moine, M. O. Peny, E. Quertinmont, D. Fokan, M. Goldman, and J. Devière. 1997. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 25: 1382-1389.
27. Ajuebor, M. N., C. M. Hogaboam, T. Le, and M. G. Swain. 2003. C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. J. Immunol. 170: 5252-5259.
28. Chang, W. S., J. Y. Kim, Y. J. Kim, Y. S. Kim, J. M. Lee, M. Azuma, H. Yagita, and C. Y. Kang. 2008. Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy. J. Immunol. 181: 6707-6710.
29. Miller, M. L., Y. Sun, and Y. X. Fu. 2009. Cutting edge: B and T lymphocyte attenuator signaling on NKT cells inhibits cytokine release and tissue injury in early immune responses. J. Immunol. 183: 32-36.
30. Wang, Y., S. K. Subudhi, R. A. Anders, J. Lo, Y. Sun, S. Blink, Y. Wang, J. Wang, X. Liu, K. Mink, et al. 2005. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J. Clin. Invest. 115: 711-717.
31. Anand, S., P. Wang, K. Yoshimura, I. H. Choi, A. Hilliard, Y. H. Chen, C. R. Wang, R. Schulick, A. S. Flies, D. B. Flies, et al. 2006. Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J. Clin. Invest. 116: 1045-1051.
32. Crawford, A., and E. J. Wherry. 2009. Editorial: Therapeutic potential of targeting BTLA. J. Leukoc. Biol. 86: 5-8.
33. Wang, J., L. Cheng, Z. Wondimu, M. Swain, P. Santamaria, and Y. Yang. 2009. Cutting edge: CD28 engagement releases antigen-activated invariant NKT cells from the inhibitory effects of PD-1. J. Immunol. 182: 6644-6647.
34. Kawamura, T., K. Takeda, H. Kaneda, H. Matsumoto, Y. Hayakawa, D. H. Raulet, Y. Ikarashi, M. Kronenberg, H. Yagita, K. Kinoshita, et al. 2009. NKG2A inhibits invariant NKT cell activation in hepatic injury. J. Immunol. 182: 250-258.
35. + regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice. J. Immunol. 181: 7221-7229.